These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24852117)

  • 1. BINGO: targeted therapy for advanced biliary-tract cancer.
    Valle JW
    Lancet Oncol; 2014 Jul; 15(8):778-80. PubMed ID: 24852117
    [No Abstract]   [Full Text] [Related]  

  • 2. Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial.
    Malka D; Cervera P; Foulon S; Trarbach T; de la Fouchardière C; Boucher E; Fartoux L; Faivre S; Blanc JF; Viret F; Assenat E; Seufferlein T; Herrmann T; Grenier J; Hammel P; Dollinger M; André T; Hahn P; Heinemann V; Rousseau V; Ducreux M; Pignon JP; Wendum D; Rosmorduc O; Greten TF;
    Lancet Oncol; 2014 Jul; 15(8):819-28. PubMed ID: 24852116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to move to targeted drugs in biliary tract cancer?
    Louvet C; Tournigand C
    Onkologie; 2010; 33(1-2):10-1. PubMed ID: 20164655
    [No Abstract]   [Full Text] [Related]  

  • 4. Preliminary experience of cetuximab in the treatment of advanced-stage biliary tract cancer.
    Chang PY; Cheng MF; Lee HS; Hsieh CB; Yao NS
    Onkologie; 2010; 33(1-2):45-7. PubMed ID: 20164661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to cetuximab and gemcitabine-oxaliplatin in an advanced case of intrahepatic cholangiocarcinoma.
    Bralet MP; Bellin MF; Guettier C; Adam R; Paule B
    Clin Oncol (R Coll Radiol); 2006 Jun; 18(5):426. PubMed ID: 16817335
    [No Abstract]   [Full Text] [Related]  

  • 6. Biliary Tract Cancers: Finding Better Ways to Lump and Split.
    Kelley RK; Bardeesy N
    J Clin Oncol; 2015 Aug; 33(24):2588-90. PubMed ID: 26195717
    [No Abstract]   [Full Text] [Related]  

  • 7. Dramatic response to trastuzumab and paclitaxel in a patient with human epidermal growth factor receptor 2-positive metastatic cholangiocarcinoma.
    Law LY
    J Clin Oncol; 2012 Sep; 30(27):e271-3. PubMed ID: 22851567
    [No Abstract]   [Full Text] [Related]  

  • 8. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
    Furuse J; Okusaka T; Funakoshi A; Yamao K; Nagase M; Ishii H; Nakachi K; Ueno H; Ikeda M; Morizane C; Horikawa Y; Mizuno N
    Jpn J Clin Oncol; 2006 Sep; 36(9):552-6. PubMed ID: 16887837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic therapy of cholangiocarcinoma: From chemotherapy to targeted therapies.
    Schweitzer N; Vogel A
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):345-53. PubMed ID: 25966433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraarterial 5-fluorouracil and interferon therapy is safe and effective for nonresectable biliary tract adenocarcinoma.
    Yashima Y; Sato S; Kawai T; Sugimoto T; Sato T; Kanda M; Obi S
    Hepatol Int; 2015 Jan; 9(1):142-8. PubMed ID: 25788388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trials.
    Subbiah IM; Subbiah V; Tsimberidou AM; Naing A; Kaseb AO; Javle M; Fu S; Hong DS; Piha-Paul S; Wheler JJ; Hess KR; Janku F; Falchook GS; Wolff RA; Kurzrock R
    Oncotarget; 2013 Jan; 4(1):156-65. PubMed ID: 23391555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted therapy for biliary tract cancers.
    Faris JE; Zhu AX
    J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):326-36. PubMed ID: 22318523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic therapy for hepatocellular carcinoma and cholangiocarcinoma.
    Chung V
    Surg Oncol Clin N Am; 2015 Jan; 24(1):187-98. PubMed ID: 25444475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial chemotherapy and conformal radiation abolish malignant biliary obstruction.
    Guan YS; Qing He ; Ping Li ; Fu YC; Zhao SW
    Integr Cancer Ther; 2008 Mar; 7(1):51-3. PubMed ID: 18292595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-1 Inhibitors Plus Capecitabine as Maintenance Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Case Report and Review of Literature.
    Wang Z; Zeng T; Li Y; Zhang D; Yuan Z; Huang M; Yang Y; Zhou W
    Front Immunol; 2021; 12():799822. PubMed ID: 35003124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regional chemotherapy in experimental cholangiocarcinoma in pigs].
    Dufek V; Petrtýl J
    Cas Lek Cesk; 1998 Aug; 137(15):464-6. PubMed ID: 9748745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant response to anti-PD-1 based immunotherapy plus lenvatinib for recurrent intrahepatic cholangiocarcinoma with bone metastasis: A case report and literature review.
    Chen WX; Li GX; Hu ZN; Zhu P; Zhang BX; Ding ZY
    Medicine (Baltimore); 2019 Nov; 98(45):e17832. PubMed ID: 31702638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Sporadic Case of Advanced Metastatic Cholangiocarcinoma in a Child: A Case Report and Review of Literature.
    Hall C; Mamlok V; Al-Khalil I
    J Pediatr Hematol Oncol; 2015 Jul; 37(5):e333-5. PubMed ID: 25851556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholangiocarcinoma.
    Squadroni M; Tondulli L; Gatta G; Mosconi S; Beretta G; Labianca R
    Crit Rev Oncol Hematol; 2017 Aug; 116():11-31. PubMed ID: 28693792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.